Merix Bioscience, Inc.
Records under this name other than patents Merix Bioscience, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 9 of 9 · Back to Merix Bioscience, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,785,583 | In situ maturation of dendritic cells Formerly held Term ended Term ended Sep 1, 2025 · From the USPTO record | Term ended | Term ended Sep 1, 2025 | From the USPTO record |
| US 8,236,562 | Method for producing ready to use, antigen-loaded or unloaded, cryoconserved mature dendritic cells Formerly held Term ended Term ended May 29, 2022 · From the USPTO record | Term ended | Term ended May 29, 2022 | From the USPTO record |
| US 8,574,901 | Cryoconserved mature dendritic cells Formerly held Term ended Term ended Aug 24, 2021 · From the USPTO record | Term ended | Term ended Aug 24, 2021 | From the USPTO record |
| US 6,274,378 | Methods and compositions for obtaining mature dendritic cells Formerly held Term ended Term ended Oct 27, 2018 · From the USPTO record | Term ended | Term ended Oct 27, 2018 | From the USPTO record |
| US 7,198,948 | Methods and compositions for obtaining mature dendritic cells Formerly held Term ended Term ended Feb 12, 2016 · From the USPTO record | Term ended | Term ended Feb 12, 2016 | From the USPTO record |
| US 7,659,119 | Method and compositions for obtaining mature dendritic cells Formerly held Term ended Ended no later than Feb 12, 2016 · From the USPTO record | Term ended | Ended no later than Feb 12, 2016 | From the USPTO record |
| US 6,475,483 | Method for in vitro proliferation of dendritic cell precursors and their use to produce immunogens for treating autoimmune diseases Formerly held Term ended Term ended Apr 1, 2012 · From the USPTO record | Term ended | Term ended Apr 1, 2012 | From the USPTO record |
| US 5,851,756 | Method for in vitro proliferation of dendritic cell precursors and their use to produce immunogens Formerly held Term ended Term ended no later than Dec 22, 2018 · Low confidence | Term ended | Term ended no later than Dec 22, 2018 | Low confidence |
| US 5,994,126 | Method for in vitro proliferation of dendritic cell precursors and their use to produce immunogens Formerly held Term ended Term ended no later than Nov 30, 2019 · Low confidence | Term ended | Term ended no later than Nov 30, 2019 | Low confidence |